|Articles|September 1, 2003
Let's Resist Biologics 'Warfare'
The advent of biologic therapies is providing dermatologists with a wholenew arsenal of medications to treat people with moderate to severe psoriasis.For the first time in many years, dermatologists have a unique opportunityto provide, perhaps, better care to our psoriasis patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













